The recruitment of participants in the clinical study assessing efficacy of corneal phototherapy with Vetuvir and Visioflavin for the treatment of spetic corneal ulcers has been completed. A total of 43 participants were recruited, including 25 dogs and 18 horses; 26 participants were randomized to receive corneal phototherapy and 17 to antimicrobial eye drops.
Stay tuned with us to be updated on the final clinical outcomes of VETUVIR and VISIOFLAVIN for treating septic corneal ulcer. Our products and protocol will definitely show their superiority over the standard-of-care.
